GVK Biosciences (GVK BIO), a drug discovery research and development organisation, has entered into an alliance with the Moulder Centre for Drug Discovery Research at Temple University, Philadelphia.

Announcing the alliance here on Monday, Manni Kantipudi, Chief Executive Officer, GVK Biosciences, said that as part of the collaboration, GVK Bio would be responsible for the target validation, lead identification and lead optimisation of small molecules in selected therapeutic areas, including cardiovascular, metabolic and central nervous system disorders.